Study: Cholesterol was lowered with an oral PCSK9 inhibitor.

Published Date: 08 Mar 2023

A new study conducted by Baylor College of Medicine and presented at the American College of Cardiology Annual Scientific Session as well as the World Congress of Cardiology shows that an oral PCSK9 inhibitor called MK-0616...

Read Full News

Latest News

Wireless Monitoring Saves Time, May Save Lives

Continuous wireless monitoring reduced in-hospital complications and mortality in an Italian pilot trial and significantly eased nursing workload.

Guideline Offers Holistic View of Brain-Heart Comorbidities

The aim of the new guideline is to expand on current cardiovascular guidelines to include evidence from the neurologic and mental health literature.

Goodbye, Prediabetes, Hello, Type 2 Diabetes Stages?

Leaders in the diabetes field are proposing eliminating the prediabetes label in favor of type 2 diabetes stages.

TAVR Embolic Protection Devices Go Head to Head: PROTECT H2H

A device designed to capture more TAVR procedural debris proves noninferior to an existing device in a large trial, but the role of these devices remains unresolved.

Vascular Complications Tied to Poor CRC Outcomes in Diabetes

In patients with colorectal cancer undergoing major resection surgery, a greater severity of diabetes-related vascular complications is linked to poorer postoperative outcomes, including mortality.


Todays Updates

Brexpiprazole Safe, Effective in Early-Episode Schizophrenia

Brexpiprazole is linked to reduced symptoms, improved functioning, and greater response compared with placebo in patients with early-episode schizophrenia, new research shows.

Oncology Care Model’s Net Losses Well Exceed Savings

But the CMS’s cancer-focused alternative payment model’s losses “mask successes” that should serve as lessons, experts say.

Todays Updates

Brexpiprazole Safe, Effective in Early-Episode Schizophrenia

Brexpiprazole is linked to reduced symptoms, improved functioning, and greater response compared with placebo in patients with early-episode schizophrenia, new research shows.

Oncology Care Model’s Net Losses Well Exceed Savings

But the CMS’s cancer-focused alternative payment model’s losses “mask successes” that should serve as lessons, experts say.

Latest News

Continuous wireless monitoring reduced in-hospital complications and mortality in an Italian pilot trial and significantly eased nursing workload.

The aim of the new guideline is to expand on current cardiovascular guidelines to include evidence from the neurologic and mental health literature.

Leaders in the diabetes field are proposing eliminating the prediabetes label in favor of type 2 diabetes stages.

A device designed to capture more TAVR procedural debris proves noninferior to an existing device in a large trial, but the role of these devices remains unresolved.

In patients with colorectal cancer undergoing major resection surgery, a greater severity of diabetes-related vascular complications is linked to poorer postoperative outcomes, including mortality.

News All Time

AI Tool Predicts LDL Without Direct Testing

A machine learning model predicts low-density lipoprotein cholesterol from routine lab data, offering a low-cost way to identify high-risk patients.

From Prediabetes to CVD in 20 Years: The Risk Gets Real

People with impaired fasting glucose levels face a higher risk for cardiovascular diseases and the onset of diabetes than those with normal fasting glucose levels.

Sleeve Gastrectomy Tied to Improved Vascular Markers

After sleeve gastrectomy, carotid intima-media thickness and multiple inflammatory, lipid, oxidative, and fibrinolytic markers decline, with oxidized LDL levels predicting carotid thickening.

Proposed Act Would Fill Gaps in Cancer Survivorship Care

If passed, the Comprehensive Cancer Survivorship Act would establish a national standard of care for cancer survivors.

Low-Dose Aspirin Underutilized as Preeclampsia Prevention

Women at high risk for preeclampsia often do not receive recommended preventive treatment.

Even Low HIV Load Can Double Heart Disease Risk

Low HIV viral load appears to raise the risk for new cardiovascular events in people with HIV, indicating the need for tailored prevention and testing of novel interventions.

EU Widens Access for Rare Lipid and Obesity Disorders

The European Medicines Agency has backed wider use of treatments for rare cholesterol and obesity disorders, offering new hope for adult and pediatric patients with limited options.

Health Risk May Vary by Alcohol Type

Beer, cider, and spirits are more harmful than wine at low-to-moderate consumption levels.

PCI Reduces Symptoms of Chronic Total Occlusion

A small carefully constructed and blinded clinical trial confirms that percutaneous intervention significantly relieves angina in patients with chronic total obstruction.

Fibrinolytic Beats Current Standard for Intermediate-Risk PE

For intermediate-risk pulmonary embolism, a low-dose fibrinolysis strategy reduced PE-related events by half with no significant increase in bleeding vs standard therapy.

LAAC an Alternative for NOAC in Lower-Risk AF Patients

CHAMPION-AF finds left atrial appendage closure and anticoagulation therapy for atrial fibrillation about equal but raises doubts about whether the former is a true alternative.

PCKS9 Inhibitors Seen Driving Down LDL-C in Diabetes

A subgroup analysis of the VESALIUS-CV trial showed evolocumab significantly cut LDL cholesterol and cardiovascular event risk in people with diabetes but no known atherosclerosis.

High Dx Yield Supports Workup for INOCA

Performed with favorable safety, the diagnostic yield for coronary function testing in patients with ischemia but nonobstructive arteries was found to exceed 90%.

Extensive Screen Time Tied to CV Risk

Screen time is identified as an independent cardiovascular risk factor in an observational study of young adults living in Pakistan.

When Self-Reflection Becomes a Physician’s Enemy

Medical training makes self-examination a core virtue. But for many physicians, a habit meant to promote growth can quietly curdle into something damaging.

Knowledge Areas: Transforming Hospital Care

Vall d’Hebron reorganized care into Knowledge Areas; the Heart Area pilot cut length of stay by 18%, 30-day readmissions by 12%, and in-hospital mortality by 48% — early but promising.

Recommended News For You

More cancer cases in areas where incarceration rates are high: Study

A new mechanism of radioresistance formation demonstrated in lung adenocarcinoma

Higher Risk of Kidney Cancer Recurrence After Ablative Therapy

'CDC Must Be Investigated'; David Lynch, Bob Uecker Die; Nasal Epinephrine Warning

Talk About Medication Costs, Bringing Back Touch, and Understanding From Dish Tumors.

An inhibitor of JAK1 exhibits "remarkable" activity in T-cell lymphoma.

Genetics and Genetic Testing to Inform Myelofibrosis Clinical Management.

Recommended Articles For You

The Importance of Corrected Calcium Levels in Managing Health Conditions  

Ultimate Guide to Oncology Services in the USA 

Thyroidectomy & Survival: Highlights from ASCO 2025 and Current U.S. Findings 

Nuclear Medicine's Role in Battling Women's Cancers 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Biocomputer From Human Neurons Plays Doom, Raises Ethics

2.

Cancer Patients Who Completed Medication Survey Received More Help From Pharmacists

3.

Parents, teachers at Missouri school want answers after string of cancer diagnoses

4.

Scientists develop scans that light up aggressive cancer tumors for better treatment

5.

Reduced Suicide Rates in Cancer Patients; Enhanced Circadian Rhythm; HIV Vaccine for Cancer Patients?

1.

HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia

2.

Don't Ignore Your Vision Loss: What You Need to Know About Amaurosis Fugax 

3.

Vaso Occlusive Crisis: Understanding the Painful Reality of Sickle Cell Disease

4.

A Closer Look at the Effects of Sickle Cell on Eyesight

5.

Innovative Intraoperative Therapies in Neurosurgical Oncology: Advancing Precision and Outcomes

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V

2.

Post Progression Approaches After First-line Third-Generaion ALK Inhibitors

3.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion

4.

The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management

5.

Efficient Management of First line ALK-rearranged NSCLC - Part VIII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot